Site içinde arama yapın

Shreya Patil bir ses eklendi Other
2025-06-25 04:19:57 -

Breast Cancer Diagnostics Market Key Drivers, Growth Opportunities and Competitive Outlook
Breast Cancer Diagnostics Market, By Test Type (Imaging, Biopsy, Genomic Test, Blood Test, and Others), Type (Ductal In Situ Carcinoma, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centers, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others) Industry...

0 Yorumlar 0 hisse senetleri 138 Views

Please log in to like, share and comment!
Daisy Miller bir ses eklendi Health
2025-02-21 05:57:59 -

Capecitabine in the Treatment of Metastatic Breast Cancer
Metastatic breast cancer (MBC) remains one of the most challenging malignancies to treat, requiring a multimodal approach for effective management. Chemotherapy plays a vital role in treatment, especially for patients with hormone receptor-negative or HER2-positive disease who do not respond to targeted therapies. Among the chemotherapeutic agents, capecitabine has emerged as a cornerstone in...

0 Yorumlar 0 hisse senetleri 882 Views

Please log in to like, share and comment!
Ava Davis bir ses eklendi Health
2025-07-04 06:32:15 -

How Ralista 60mg Works to Protect Women from Breast Cancer
Breast cancer continues to be one of the most common and concerning health threats facing women today. Especially in postmenopausal women, the risk of developing breast cancer can increase due to hormonal imbalances, genetic factors, and lifestyle influences. Fortunately, modern medicine has developed preventive strategies, including medications like Ralista 60mg—a tablet designed to...

0 Yorumlar 0 hisse senetleri 36 Views

Please log in to like, share and comment!
Rahul Rangwa bir ses eklendi Other
2025-06-23 07:01:34 -

Rising Awareness Spurs Growth in BRCA1 and BRCA2 Genetic Testing Market
"Executive Summary Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market : Data Bridge Market Research analyses that the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market, which is USD 5.62 billion in 2022, is expected to reach USD 11.28 billion by 2030, at a CAGR of 9.10% during the forecast period 2023 to 2030. Breast Cancer 1 (BRCA1) and Breast Cancer...

0 Yorumlar 0 hisse senetleri 173 Views

Please log in to like, share and comment!